---
figid: PMC7941705__12871_2021_1294_Fig2_HTML
figlink: pmc/articles/PMC7941705/figure/Fig2/
number: F2
caption: 'Anesthetic affect pro- and anti-cancer miRNA expressions leading to cancer
  biology changes. a. Inhalational anesthetic reagents modulate miRNA expressions.
  Isoflurane exposure to ovarian cancer cells increases glycolysis via PI3K/Akt pathway
  and HIF-1α by miR-21 upregulation, one of oncogenes. Sevoflurane inhibits cancer
  cell proliferation via PI3K/Akt pathway with miR-203 upregulation in breast cancer
  cells. In CRC, sevoflurane reduces cancer invasion and migration via the suppression
  of ERK pathway and MMP-9 by miR-203 upregulation. For glioma cells, sevoflurane
  increases miR-637 expressions resulting in the decrease of cancer migration and
  invasion via Akt pathway inhibition. b. Propofol exposure alters anti-cancer miRNAs.
  Propofol upregulates miR-143 in osteosarcoma cells, decreasing cancer cell proliferation
  by MMP-13 inhibition via PI3K/Akt pathway. In gastric cancer cells, propofol exposure
  induces apoptosis via PI3K/Akt pathway and MMP-2 by miR-218 upregulation whereas
  propofol causes apoptosis by miR-451 in glioblastoma cells. For hepatocellular carcinoma,
  propofol decreases MMP-9 expression by PI3K/Akt pathway suppression via miR-199a
  upregulation. Ov: ovarian cancer cell, BC: breast cancer cell, G: glioma, CRC: colorectal
  cancer, OS: osteosarcoma, GC: gastric cancer, GB: glioblastoma, HCC: hepatocellular
  carcinoma, PI3K/Akt: Phosphatidylinositol 3-kinase/protein kinase B, ERK1/2: extracellular
  signal-regulated kinases 1 and 2, HIF-1α: hypoxia-inducible factors 1α, NF-κB: nuclear
  factor-κB, VEGF: vascular endothelial growth factor, MMP: matrix metallopeptidases'
pmcid: PMC7941705
papertitle: 'Anesthetics may modulate cancer surgical outcome: a possible role of
  miRNAs regulation.'
reftext: Masashi Ishikawa, et al. BMC Anesthesiol. 2021;21:71.
pmc_ranked_result_index: '8807'
pathway_score: 0.9644113
filename: 12871_2021_1294_Fig2_HTML.jpg
figtitle: Anesthetic affect pro- and anti-cancer miRNA expressions leading to cancer
  biology changes
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7941705__12871_2021_1294_Fig2_HTML.html
  '@type': Dataset
  description: 'Anesthetic affect pro- and anti-cancer miRNA expressions leading to
    cancer biology changes. a. Inhalational anesthetic reagents modulate miRNA expressions.
    Isoflurane exposure to ovarian cancer cells increases glycolysis via PI3K/Akt
    pathway and HIF-1α by miR-21 upregulation, one of oncogenes. Sevoflurane inhibits
    cancer cell proliferation via PI3K/Akt pathway with miR-203 upregulation in breast
    cancer cells. In CRC, sevoflurane reduces cancer invasion and migration via the
    suppression of ERK pathway and MMP-9 by miR-203 upregulation. For glioma cells,
    sevoflurane increases miR-637 expressions resulting in the decrease of cancer
    migration and invasion via Akt pathway inhibition. b. Propofol exposure alters
    anti-cancer miRNAs. Propofol upregulates miR-143 in osteosarcoma cells, decreasing
    cancer cell proliferation by MMP-13 inhibition via PI3K/Akt pathway. In gastric
    cancer cells, propofol exposure induces apoptosis via PI3K/Akt pathway and MMP-2
    by miR-218 upregulation whereas propofol causes apoptosis by miR-451 in glioblastoma
    cells. For hepatocellular carcinoma, propofol decreases MMP-9 expression by PI3K/Akt
    pathway suppression via miR-199a upregulation. Ov: ovarian cancer cell, BC: breast
    cancer cell, G: glioma, CRC: colorectal cancer, OS: osteosarcoma, GC: gastric
    cancer, GB: glioblastoma, HCC: hepatocellular carcinoma, PI3K/Akt: Phosphatidylinositol
    3-kinase/protein kinase B, ERK1/2: extracellular signal-regulated kinases 1 and
    2, HIF-1α: hypoxia-inducible factors 1α, NF-κB: nuclear factor-κB, VEGF: vascular
    endothelial growth factor, MMP: matrix metallopeptidases'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT3
  - AKT1
  - MAPK3
  - MAPK1
  - HIF1A
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - MMP2
  - MMP9
  - MMP13
  - GC
  - FAM126A
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - Isoflurane
  - Sevoflurane
  - Propofol
  - cancer
genes:
- word: РІЗК/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: РІЗК/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: РІЗК/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HIF1A
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: MMP2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: МMP13
  symbol: MMP13
  source: hgnc_symbol
  hgnc_symbol: MMP13
  entrez: '4322'
- word: (GC)
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: (HCC)
  symbol: HCC
  source: hgnc_alias_symbol
  hgnc_symbol: FAM126A
  entrez: '84668'
- word: РІЗК/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: РІЗК/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: РІЗК/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: HIF1A
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: MMP2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: MMP13
  symbol: MMP13
  source: hgnc_symbol
  hgnc_symbol: MMP13
  entrez: '4322'
chemicals:
- word: Isoflurane
  source: MESH
  identifier: D007530
- word: Sevoflurane
  source: MESH
  identifier: C009250
- word: Propofol
  source: MESH
  identifier: D015742
diseases:
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7941705__F2
redirect_from: /figures/PMC7941705__F2
figtype: Figure
---
